• Phenothiazines, ROS, and Macrophage Autophagy

  2026-08-15

  A 2025 Frontiers in Immunology study shows that phenothiazines can strengthen macrophage antibacterial activity through coordinated increases in reactive oxygen species, lysosomal function, and autophagy. Pharmacological inhibition of autophagy or ROS reduced this effect, while perphenazine improved inflammatory and tissue outcomes in a Salmonella Typhimurium infection model, supporting phenothiazines as lead compounds for host-directed antibacterial research.

• GS967: Cardiac Late Sodium Current Inhibitor

  2026-08-14

  GS967 enables targeted studies of pathological late sodium influx in ventricular myocytes, isolated hearts, aging models, and arrhythmia paradigms. Its concentration- and voltage-dependent activity supports experimental separation of late INa effects from broader conduction changes.

• GS967: Cardiac Late Sodium Current Inhibitor

  2026-08-14

  GS967 enables targeted interrogation of pathological late sodium influx in ventricular myocytes, aging models, isolated hearts, and ischemia-related arrhythmia assays. Its concentration- and voltage-dependent activity supports workflows that separate late sodium current effects from broader changes in cardiac conduction.

• Sabutoclax: From Viability Readouts to Cell Death

  2026-08-13

  Sabutoclax is a pan-Bcl-2 inhibitor whose effects can be interpreted more accurately by separating growth suppression from actual cell killing. This guide combines its multi-target pharmacology with a dissertation-based framework for selecting time-resolved, orthogonal cancer assays.

• CSBTA Pharmacokinetics in MASH: Study Insights

  2026-08-13

  The reference study integrates plasma pharmacokinetics, tissue distribution, cellular accumulation, transporter assays, and metabolic-enzyme analysis to explain how MASH changes exposure to Corydalis saxicola Bunting total alkaloids. Its findings show that disease state and repeated dosing can increase systemic and hepatic exposure, providing a mechanistic basis for disease-adjusted dosing strategies.

• RAB31 and ESCRT-Independent Exosome Biogenesis

  2026-08-12

  The reference study identifies RAB31 as a regulator of an ESCRT-independent exosome pathway in which EGFR-activated RAB31 engages flotillin microdomains to promote intraluminal vesicle formation. It also links RAB31 to TBC1D2B-mediated RAB7 inactivation, showing how one regulatory module can both generate vesicles and protect multivesicular endosomes from lysosomal degradation.

• GS967: Cardiac Late Sodium Current Workflows

  2026-08-12

  GS967 enables targeted suppression of pathological late sodium influx in cellular, tissue, and whole-heart models. Its concentration-dependent activity supports aging, ischemia, and torsades de pointes workflows while preserving a practical path for separating late-current effects from broader conduction changes.

• Valemetostat in Reliable Lymphoma Assays

  2026-08-11

  This scenario-based guide explains how Valemetostat (SKU BA4816) can be integrated into viability, proliferation, and cytotoxicity workflows without confusing biochemical potency with cellular response. It covers solvent compatibility, exposure design, EZH2-mutant comparisons, interpretation of lymphoma data, and practical product-selection criteria.

• BCL-XL inhibitor A-1155463 Workflow Guide

  2026-08-11

  Build more informative apoptosis assays with the selective BCL-XL inhibitor A-1155463, from DMSO stock preparation through orthogonal validation and in vivo translation. The workflow emphasizes functional BCL-XL dependence, resistance biology, and practical controls rather than relying on protein expression alone.

• ABT-888 (Veliparib) for DNA Repair Studies

  2026-08-10

  ABT-888 (Veliparib) is a selective PARP1/2 inhibitor for testing DNA repair inhibition alongside chemotherapy or radiation. Its strongest use-case is not a universal sensitizer claim, but a controlled platform for comparing genotype, treatment schedule, and tumor-model context.

• Imipramine in Cell Viability and Autophagy Research

  2026-08-09

  Learn how Imipramine, SKU BA2970, can support reproducible cell viability, autophagy, and apoptosis workflows when metabolic signals are interpreted alongside orthogonal measurements. This scenario-based guide covers assay design, concentration planning, storage, data analysis, and practical product selection for biomedical research.

• Dovitinib (TKI-258) Workflow for RTK Cancer Studies

  2026-08-08

  Dovitinib (TKI-258) enables pathway-focused studies that connect RTK blockade with proliferation, ERK/STAT signaling, and apoptosis. This workflow also translates a HER2-therapy-resistance study into practical assay design without overstating what has been experimentally demonstrated.

• GLI2, WNT, and Prostaglandins in ICB Resistance

  2026-08-07

  The reference study identifies GLI2 as a mechanistic link between mesenchymal transformation and tumor immune evasion, showing that GLI2 coordinates WNT ligand production with prostaglandin signaling. Its findings suggest that pathway-specific combinations, rather than GLI2-associated biology alone, may help reverse myeloid suppression and resistance to anti-PD-1 therapy.

• NU6300 Blocks Gasdermin D Pyroptosis via Cysteine-191 Target

  2026-08-07

  The reference study identifies NU6300 as a covalent inhibitor of gasdermin D (GSDMD), acting through direct modification of cysteine-191 to block GSDMD cleavage and palmitoylation. These findings elucidate a new regulatory mechanism for pyroptosis and suggest new therapeutic strategies for inflammatory diseases.

• Fingolimod (FTY720): S1P Modulation and Immunotherapy Integr

  2026-08-06

  Fingolimod (FTY720) is a potent, orally active S1P receptor modulator approved for multiple sclerosis. Its dual mechanism—lymphocyte egress inhibition and CNS neuroprotection—makes it a cornerstone for both clinical and experimental immunomodulation. Quantitative benchmarks and protocol parameters enable reliable deployment in translational immunology and emerging immune engineering workflows.

16273 records 1/1085 page Next 12345 下5页 Last page